Author: Customer Service

*** Limited places remain available for institutional investors for this previously announced Investor Access Event *** WASHINGTON, Oct. 10, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it will host an Institutional Investor Access Event in South Africa from November 11-13, 2025. **There is also the possibility of adding an extra day to the trip and visiting the Renergen Virginia Gas Project on November 14th – please let us know if you are also interested in attending that day too. (subject to numbers)** All investors are invited to request a registration to attend the Institutional Investor Access Event. ASP...

SINGAPORE, Oct. 10, 2025 (GLOBE NEWSWIRE) — INNEOVA Holdings Limited (“INNEOVA Holdings” or the “Company”) (Nasdaq: INEO), through INNEOVA Engineering, a Singapore-based engineering solutions provider that maximizes equipment uptime, minimizes total ownership costs, and extends asset lifecycles through sustainable practices, today provided investors with an update on its hydrogen energy initiatives following the September 2025 signing of a Memorandum of Understanding with HyCee Pte. Ltd., a joint venture of GuoFu Hydrogen (“Jiangsu Guofu Hydrogen Energy Equipment Co. Ltd”) Since establishing the partnership, INNEOVA Engineering has advanced its strategic positioning as a pathfinder for hydrogen adoption in Singapore, aligning with the nation’s ambitious decarbonization roadmap. Singapore’s National Hydrogen Strategy,...

Taipei, Taiwan, Oct. 10, 2025 (GLOBE NEWSWIRE) — YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that its business partner, EG Biomed US Inc. (“EG BioMed”) one of the Company’s licensing partners for pancreatic and breast cancer detection and with 3D Global to develop treatment for eye disorders, has been accredited by the College of American Pathologists’ (CAP) Laboratory Accreditation Program for its CLIA-certified laboratory in Bothell, Washington (CLIA Certificate #50D2316600). CAP accreditation, widely recognized as the gold standard in laboratory quality assurance, confirms that EG BioMed meets the highest standards of excellence in laboratory operations. Together with its existing...

MALVERN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced that it has entered into definitive agreements for the purchase of an aggregate of 4,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.50 per share (or pre-funded warrant in lieu thereof) in a registered direct offering. The closing of the offering is expected to occur on or about October 13, 2025, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company...

MUSCATINE, Iowa, Oct. 10, 2025 (GLOBE NEWSWIRE) — On August 4, 2025, HNI Corporation (NYSE: HNI; “HNI” or “the Corporation”) announced a definitive agreement to acquire Steelcase, Inc. (NYSE: SCS; “Steelcase”) in a cash and stock transaction (the “Acquisition”). In connection with the Acquisition, HNI previously announced the commencement of an offer to exchange any and all outstanding 5.125% Notes due 2029 (the “Existing Steelcase Notes”), as issued by Steelcase, for up to $450,000,000 aggregate principal amount of new notes to be issued by HNI (the “New HNI Notes”). HNI today announced that it has received consents from Eligible Holders (as defined herein) representing 77.83% in principal amount of the Existing Steelcase Notes pursuant to HNI’s previously announced (A) offer to exchange (the “Exchange Offer”) any and all...

CULVER CITY, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today announced a series of cross-industry partnerships to expand visibility, diversify audiences, and drive long-term growth potential for upcoming indie titles, Above the Snow and Rebel Engine. Above the Snow, a cozy, story-rich shelter management sim set in the 1960s Alps, blends survival mechanics with character-driven storytelling and base-building. Building on its momentum after winning a NYX Award for best city builder, Above the Snow will also be showcased at the upcoming Poznan Game Arena October 24-26, 2025, one of the biggest gaming events in Eastern Europe. During the event, Above the Snow will unveil collaborations...

GLENVIEW, Ill., Oct. 10, 2025 (GLOBE NEWSWIRE) — Illinois Tool Works Inc. (NYSE: ITW) will issue its third quarter 2025 results on Friday, October 24, 2025, at 7:00 a.m. CDT. Following the release, ITW will hold its third quarter 2025 earnings webcast at 9:00 a.m. CDT. To access the webcast for the event, please click on the following link:ITW Q3 2025 Earnings Webcast If you are a participant on the conference call, please dial 1-888-660-6652 (domestic) or 1-646-960-0554 (international) 10 minutes prior to the 9:00 a.m. CDT start time. The passcode is “ITW.” Following the webcast, presentation materials and an audio webcast replay will be available at http://investor.itw.com. An audio-only replay will be available from October 24 through October 31 by dialing 1-800-770-2030 (domestic) or 1-609-800-9909 (international). The passcode...

CHICAGO, Oct. 10, 2025 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $500,000 worth of Ethereum (ETH), bringing its total investment in ETH to $1.5 million. This acquisition was executed pursuant to Cosmos Health’s previously announced $300 million digital assets facility, which is part of the Company’s broader strategic initiative to diversify its balance sheet and leverage blockchain technology within the healthcare and digital wellness sectors. Greg Siokas, CEO of Cosmos Health, stated: “We are pleased to continue our Ethereum purchases and reiterate our commitment to fully leveraging our $300 million financing facility. We are already seeing gains from our earlier...

LONG BEACH, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has signed a direct contract for two dedicated Electron launches with the Japan Aerospace Exploration Agency (JAXA) – signifying the criticality of Electron to international space agencies requiring responsive launch and dedicated access to space. Launching from Rocket Lab Launch Complex 1 in New Zealand, the two Electron missions will deploy satellites for JAXA’s Innovative Satellite Technology Demonstration Program. The first launch, scheduled from December 2025, will deploy the agency’s RApid Innovative payload demonstration SatellitE-4 (RAISE-4) spacecraft, a single satellite that will demonstrate eight technologies developed by private...